Offenbach, Germany

Lothar Biesert

This inventor holds 2 USPTO granted patents. Top assignee: Octapharma Ag. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lothar Biesert. Retrieved from https://idiyas.com/inventor/lothar-biesert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lothar Biesert: Innovator in Viral Infectiousness Reduction

Introduction

Lothar Biesert is a notable inventor based in Offenbach, Germany. He has made significant contributions to the field of viral infectiousness reduction, holding 2 patents to his name. His work focuses on methods that enhance safety in handling potentially infectious materials.

Latest Patents

One of Lothar Biesert's latest patents is a method for the reduction of the infectiousness of potentially infectious materials. This method specifically targets the viral infectiousness of human or animal body fluids or fractions derived from them. The innovation is particularly relevant for materials that contain non-lipid-coated viruses, providing a crucial advancement in bio-safety protocols.

Career Highlights

Lothar Biesert is currently associated with Octapharma AG, a company known for its commitment to developing human proteins for therapeutic use. His work at Octapharma AG has positioned him as a key player in the field of biopharmaceuticals, contributing to advancements that improve public health.

Collaborations

Lothar has collaborated with notable colleagues such as Horst Schwinn and Wolfgang Marguerre. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Lothar Biesert's contributions to the reduction of viral infectiousness highlight his role as an important inventor in the biopharmaceutical industry. His innovative methods and collaborations continue to pave the way for safer handling of potentially infectious materials.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…